Matthew Blischak
Director Ejecutivo en FINCH THERAPEUTICS GROUP, INC. .
Fortuna: - $ al 30/04/2024
Perfil
Matthew P.
Blischak is currently the President, Chief Executive Officer & Secretary at Finch Therapeutics Group, Inc. Prior to his current position, he worked as the Vice President-Intellectual Property at Roivant Sciences, Inc. from 2018 to 2023.
Mr. Blischak completed his undergraduate degree at Case Western Reserve University and his graduate degrees at The Johns Hopkins University and American University Washington College of Law.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Matthew Blischak
| Empresas | Cargo | Inicio |
|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Director Ejecutivo | 16/05/2023 |
Antiguos cargos conocidos de Matthew Blischak.
| Empresas | Cargo | Fin |
|---|---|---|
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/04/2023 |
Formación de Matthew Blischak.
| Case Western Reserve University | Undergraduate Degree |
| American University Washington College of Law | Graduate Degree |
| The Johns Hopkins University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| Empresas privadas | 1 |
|---|---|
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Matthew Blischak